elias jabbour, md, on the phase iii phallcon trial in ph all
Published 11 months ago • 321 plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
1:48
2023 eha leukemia update from elias jabbour, md
-
2:38
the hemonc pulse live at ash 2022: elias jabbour, md, on immunotherapy advances in all
-
22:55
adult: regimen related toxicity - elias jabbour, md
-
1:40
meet leukemia oncologist elias jabbour, m.d.
-
1:59
how treatment approaches to ph all have changed over the years and future outlooks
-
3:21
dr. jabbour on the excitement of being back at soho
-
1:43:36
china: o socialismo do século xxi | elias jabbour, dilma rousseff e silvio almeida
-
9:44
an update on the quantum-first trial: quizartinib plus chemotherapy in flt3-mutated aml
-
23:10
bispecific in myeloma | dr. ahmed al huraiji (17 feb 2024)
-
12:06
beyond hcvad: exploring ways to reduce myelosuppression - elias jabbour, md
-
0:48
how can i be hopeful when the numbers are scary? a doctor's answer: #cancercure #aml #leukemia #aml
-
1:26
obe-cel for r/r b-all: pooled analysis of the ongoing felix study
-
2:37
elias jabbour, md | key takeaways in leukemia cancers at 2019 asco direct highlights denver
-
6:13
ponatinib superior to imatinib in combination with reduced-intensity chemotherapy in ph-positive all
-
0:43
elias jabbour md | advice on leukemia cancers at 2019 asco direct highlights denver
-
0:53
reviewing the latest treatment advancements in all
-
1:23
dr. jabbour discusses blinatumomab in all
-
1:33
dr. jabbour on emerging subsets in all
-
0:46
dr. jabbour on second-generation tkis in cml
-
15:45
how i treat cml elias jabbour
-
4:22
chronic myeloid leukemia (cml) update - interview with elias jabbour, m.d.
-
2:24
the success of phase iii tower trial of blinatumomab in all